RNA
Avidity Biosciences Inc
Price:  
25.76 
USD
Volume:  
1,561,197.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Avidity EV/EBITDA

-272.8%
Upside

As of 2025-04-18, the EV/EBITDA ratio of Avidity Biosciences Inc (RNA) is -7.64. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Avidity's latest enterprise value is 2,876.74 mil USD. Avidity's TTM EBITDA according to its financial statements is -376.41 mil USD. Dividing these 2 quantities gives us the above Avidity EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.7x - 11.3x 9.5x
Forward P/E multiples 20.0x - 21.5x 20.1x
Fair Price (60.92) - (33.55) (44.51)
Upside -336.5% - -230.3% -272.8%
25.76 USD
Stock Price
(44.51) USD
Fair Price

Avidity EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-04-04 -7.90
2025-04-03 -8.39
2025-04-02 -8.92
2025-04-01 -7.96
2025-03-31 -8.84
2025-03-28 -9.51
2025-03-27 -9.81
2025-03-26 -9.65
2025-03-25 -9.67
2025-03-24 -10.05
2025-03-21 -9.26
2025-03-20 -9.26
2025-03-19 -9.55
2025-03-18 -9.15
2025-03-17 -10.22
2025-03-14 -9.35
2025-03-13 -9.68
2025-03-12 -9.83
2025-03-11 -8.86
2025-03-10 -9.01
2025-03-07 -9.09
2025-03-06 -9.11
2025-03-05 -8.85
2025-03-04 -8.54
2025-03-03 -8.75
2025-02-28 -9.20
2025-02-27 -8.70
2025-02-26 -8.88
2025-02-25 -8.73
2025-02-24 -9.17
2025-02-21 -9.35
2025-02-20 -9.80
2025-02-19 -9.60
2025-02-18 -9.64
2025-02-14 -9.73
2025-02-13 -9.96
2025-02-12 -9.58
2025-02-11 -10.21
2025-02-10 -10.37
2025-02-07 -10.57
2025-02-06 -10.63
2025-02-05 -10.49
2025-02-04 -10.06
2025-02-03 -9.62
2025-01-31 -9.93
2025-01-30 -9.84
2025-01-29 -9.61
2025-01-28 -9.66
2025-01-27 -9.14
2025-01-24 -8.89